Comparing methotrexate and methotrexate with methotrexate with apremilast in modifying biochemical parameters of psoriasis patients.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2023/03/050882
- Lead Sponsor
- Anisha Biswal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All Psoriasis patients >18 years of age
2. PASI >10 and or DLQI >10
Exclusion Criteria
1.Contraindications to use of any drug methotrexate or apremilast.
2.Patient known case of diabetes mellitus, hypertension, dyslipidemia
3. Patient on any other disease modifying drugs in last 6weeks.
4. Patient on any drugs confounding any metabolic parameters like hypolipidemic drugs, anti-diabetic drugs, oral contraceptives, antihypertensive drugs, acitretin, orlistat.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method